A multi-algorithm prognostic model combining inflammatory indices and surgical features in distal cholangiocarcinoma
Yi Yin1,2, Luyuan Bai3, Xinyue Mu1,2
1Pediatrics Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
The derived neutrophil-to-lymphocyte ratio (dNLR) is a significant predictor of poor prognosis in distal cholangiocarcinoma (dCCA) patients after surgery. A dNLR above 1.60 indicates higher risk, and incorporating it into models improves outcome prediction.
Area of Science:
- Oncology
- Biomarkers
- Surgical Outcomes
Background:
- The derived neutrophil-to-lymphocyte ratio (dNLR) is an emerging blood-based inflammatory biomarker.
- Previous studies indicate dNLR has prognostic value in various malignancies.
- The prognostic significance of dNLR in distal cholangiocarcinoma (dCCA) post-curative resection requires investigation.
Purpose of the Study:
- To investigate the prognostic significance of dNLR in patients with distal cholangiocarcinoma (dCCA) after curative resection.
- To evaluate the predictive value of dNLR for postoperative survival in dCCA patients.
- To develop and validate a predictive model for dCCA outcomes incorporating dNLR.
Main Methods:
- Retrospective analysis of clinicopathological data from 177 dCCA patients.
- Receiver operating characteristic (ROC) curve analysis to determine optimal dNLR cutoff (1.60).
- Kaplan-Meier analysis, machine learning models (random forest, RFE, LASSO), and Cox regression for prognostic factor identification and model development.
Main Results:
- An optimal dNLR cutoff of 1.60 was identified, with an AUC of 0.707 for predicting postoperative survival.
- Patients with high dNLR (> 1.60) had significantly worse recurrence-free and overall survival.
- Preoperative dNLR > 1.60 was identified as an independent adverse prognostic factor, improving a predictive model with other clinical variables.
Conclusions:
- Preoperative dNLR > 1.60 is an independent risk factor for poor prognosis in dCCA patients.
- A machine learning-based clinical prediction model incorporating dNLR effectively predicts postoperative outcomes in dCCA.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
